Koers Medican Enterprises, Inc. Other OTC
Aandelen
MDCN
US58464T2024
Farmaceutische producten
Omzet 2013 | - | Omzet 2014 | - | Marktkapitalisatie | 660K 616K |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | - 0 | Nettowinst (verlies) 2014 | -56 mln. -52,26 mln. | EV/omzet 2013 | - |
Nettoschuld 2013 | 117K 109K | Nettoschuld 2014 | 5,85 mln. 5,46 mln. | EV/omzet 2014 | - |
K/w-verhouding 2013 |
-21,9
x | K/w-verhouding 2014 |
-0,01
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mitchell Xavier
CEO | Chief Executive Officer | - | - |
Kenneth Williams
CHM | Chairman | 52 | 25-06-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kenneth Williams
CHM | Chairman | 52 | 25-06-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,25% | 699 mld. | |
+28,59% | 571 mld. | |
-3,55% | 364 mld. | |
+18,16% | 326 mld. | |
+4,36% | 286 mld. | |
+14,81% | 236 mld. | |
+4,93% | 198 mld. | |
-9,78% | 194 mld. | |
-3,69% | 149 mld. |